¼¼°èÀÇ ¾ÏÆ÷Å׸®½Å B ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ ¹× ¿¹Ãø - ÆÇ¸Åä³Îº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Amphotericin B Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1703438
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,957,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,575,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾ÏÆ÷Å׸®½Å B ¼¼°è ½ÃÀåÀº 2024³â¿¡ 6,941¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2030³â¿¡´Â 1¾ï 554¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ(CAGR) 2.91%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ÁÖ·Î »ý¸íÀ» À§ÇùÇÏ´Â Áø±Õ °¨¿°ÁõÀÇ ¹ßº´·ü Áõ°¡¿Í Àü ¼¼°è ¸é¿ª°áÇÌ Àα¸ Áõ°¡·Î ÀÎÇØ ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Æú¸®¿£°è Ç×Áø±ÕÁ¦ÀÎ ¾ÏÆ÷Å׸®½Å B´Â Å©¸³ÅäÄÚÄ¿½º ¼ö¸·¿°, ¾Æ½ºÆä¸£±æ·ç½ºÁõ, ¹«ÄݹÌÄڽýº, Ä­µð´ÙÁõ°ú °°Àº ÁßÁõ Àü½Å¼º Áø±ÕÁõ¿¡ ´ëÇÑ °¡Àå È¿°úÀûÀÎ Ä¡·á¹ý Áß ÇϳªÀÔ´Ï´Ù. »õ·Î¿î Ç×Áø±ÕÁ¦ÀÇ µîÀå¿¡µµ ºÒ±¸ÇÏ°í ¾ÏÆ÷Å׸®½Å B´Â ƯÈ÷ º´¿ø ȯ°æ°ú ´ÙÁ¦³»¼º »ç·Ê¿¡¼­ Áß¿äÇÑ Ä¡·á °ü·Ã¼ºÀ» À¯ÁöÇϰí ÀÖ½À´Ï´Ù. È­Çпä¹ý ¹× Àå±âÀÌ½Ä È¯ÀÚ, HIV/AIDS ȯÀÚ µî ¸é¿ª°áÇÌ È¯ÀÚ¿¡¼­ ±âȸ¼º Áø±Õ °¨¿° Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ƯÁ¤ Áö¿ª¿¡¼­ Äڷγª19°¡ À¯ÇàÇÏ´Â µ¿¾È Á¡±ÕÁõ ȯÀÚ Áõ°¡´Â ¾ÏÆ÷Å׸®½Å B¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸®Æ÷Á» Á¦Çü°ú ÁöÁú º¹ÇÕü Á¦ÇüÀÇ ¹ßÀüÀ¸·Î ¾à¹°ÀÇ ³»¾à¼ºÀÌ °³¼±µÇ°í ½Åµ¶¼ºÀÌ °¨¼ÒÇÔ¿¡ µû¶ó ÀÓ»ó Àû¿ëÀÌ ´õ¿í È®´ëµÇ°í ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·á Á¢±Ù¼º °³Ã´°ú ÀÎ½Ä Áõ°¡´Â Ç×Áø±ÕÁ¦ Ä¡·áÀÇ º¸±ÞÀ» ÃËÁøÇÏ°í ½ÃÀå ÀáÀç·ÂÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 6,941¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 1¾ï 554¸¸ ´Þ·¯
CAGR : 2025-2030³â 2.91%
±Þ¼ºÀå ºÎ¹® Á÷Á¢
ÃÖ´ë ½ÃÀå ¾Æ½Ã¾ÆÅÂÆò¾ç

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

ÇコÄÉ¾î »ê¾÷ÀÇ ¼ºÀå

ÁÖ¿ä ½ÃÀå °úÁ¦

µ¶¼º ¹× ºÎÀÛ¿ë:

ÁÖ¿ä ½ÃÀå µ¿Çâ

°õÆÎÀÌ °¨¿° Áõ°¡:

¸ñÂ÷

Á¦1Àå Á¦Ç° °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼¼°è ¾ÏÆ÷Å׸®½Å B ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¾ÏÆ÷Å׸®½Å B ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ ¾ÏÆ÷Å׸®½Å B ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ ¾ÏÆ÷Å׸®½Å B ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾ÏÆ÷Å׸®½Å B ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ ¾ÏÆ÷Å׸®½Å B ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾ÏÆ÷Å׸®½Å B ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå ¼¼°èÀÇ ¾ÏÆ÷Å׸®½Å B ½ÃÀå : SWOT ºÐ¼®

Á¦14Àå PorterÀÇ Five Forces ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå ȸ»ç ¼Ò°³ ¹× ¸éÃ¥Á¶Ç×

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Amphotericin B market was valued at USD 69.41 million in 2024 and is projected to reach USD 105.54 million by 2030, growing at a compound annual growth rate (CAGR) of 2.91% during the forecast period. The market is experiencing consistent growth, primarily driven by the rising incidence of life-threatening fungal infections and the expanding population of immunocompromised individuals worldwide. Amphotericin B, a polyene antifungal agent, remains one of the most effective treatments for severe systemic mycoses, including cryptococcal meningitis, aspergillosis, mucormycosis, and candidiasis. Despite the emergence of newer antifungal agents, Amphotericin B continues to maintain significant therapeutic relevance, especially in hospital settings and in cases of multidrug resistance. A key factor contributing to the market's growth is the increasing prevalence of opportunistic fungal infections among immunocompromised patients, such as those undergoing chemotherapy, organ transplants, or living with HIV/AIDS. The rise in mucormycosis cases, particularly during the COVID-19 pandemic in certain regions, has further heightened the demand for Amphotericin B. Moreover, advancements in liposomal and lipid complex formulations have improved drug tolerability and reduced nephrotoxicity, further enhancing clinical adoption. Expanding healthcare access and growing awareness in developing economies are also driving greater use of antifungal therapies, thereby enhancing market potential.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 69.41 Million
Market Size 2030USD 105.54 Million
CAGR 2025-20302.91%
Fastest Growing SegmentDirect
Largest MarketAsia-Pacific

Key Market Drivers

Growth in Healthcare Industry:

The continued expansion of the global healthcare sector is a major driver of the Amphotericin B market. The global hospital market is expected to generate USD 4.41 trillion in revenue by 2025. In the United States, hospitals are making significant investments in telemedicine to extend remote healthcare services, particularly in rural areas. As healthcare systems evolve and infrastructure improves in both developed and emerging economies, there is a growing emphasis on effective treatments for life-threatening fungal infections, where Amphotericin B remains a gold standard. Known for its potent antifungal properties, Amphotericin B is widely used in managing systemic mycoses, particularly in immunocompromised patients such as those with HIV/AIDS, cancer, or undergoing organ transplants.

Key Market Challenges

Toxicity and Adverse Side Effects:

A significant challenge facing the global Amphotericin B market is the drug's known toxicity and adverse side effects. Although Amphotericin B is considered a gold standard for treating severe fungal infections, its use is often limited by safety concerns, particularly nephrotoxicity, which can lead to acute kidney injury in a significant proportion of patients. Other common adverse effects include infusion-related reactions such as fever, chills, hypotension, and electrolyte imbalances. These side effects require intensive monitoring and hospitalization, thus increasing treatment costs and complexity. While liposomal and lipid-based formulations have helped mitigate some of these toxicities, their high cost limits broader adoption, particularly in resource-limited settings. The ongoing challenge of balancing efficacy with safety remains a major concern for healthcare providers and pharmaceutical manufacturers, highlighting the need for safer, equally effective alternatives or improved formulations in the antifungal therapeutics market.

Key Market Trends

Increasing Prevalence of Fungal Infections:

The rising global incidence of fungal infections has become a defining trend in the growth of the Amphotericin B market. It is estimated that invasive fungal infections occur at a rate of approximately 6.5 million cases annually, leading to around 3.8 million deaths. Of these, an estimated 2.5 million fatalities-representing 68% (ranging between 35% and 90%)-are directly caused by these infections. Invasive aspergillosis alone affects over 2.1 million individuals annually, primarily among patients with chronic obstructive pulmonary disease (COPD), those in intensive care units, and individuals with hematologic malignancies or lung cancer. This condition has a concerning mortality rate of 85.2%. With the growing number of individuals affected by opportunistic and invasive fungal diseases, the demand for potent antifungal therapies such as Amphotericin B has significantly increased.

Key Market Players

Report Scope

In this report, the Global Amphotericin B Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Amphotericin B Market, By Sales Channel:

Amphotericin B Market, By End Use:

Amphotericin B Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Amphotericin B Market.

Available Customizations:

Global Amphotericin B Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Amphotericin B Market

5. Global Amphotericin B Market Outlook

6. North America Amphotericin B Market Outlook

7. Europe Amphotericin B Market Outlook

8. Asia Pacific Amphotericin B Market Outlook

9. South America Amphotericin B Market Outlook

10. Middle East and Africa Amphotericin B Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Amphotericin B Market: SWOT Analysis

14. Porters Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â